1. Home
  2. DESP vs NVAX Comparison

DESP vs NVAX Comparison

Compare DESP & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DESP
  • NVAX
  • Stock Information
  • Founded
  • DESP 1999
  • NVAX 1987
  • Country
  • DESP British Virgin Islands
  • NVAX United States
  • Employees
  • DESP N/A
  • NVAX N/A
  • Industry
  • DESP Transportation Services
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DESP Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • DESP Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • DESP 1.6B
  • NVAX 1.3B
  • IPO Year
  • DESP 2017
  • NVAX 1995
  • Fundamental
  • Price
  • DESP $19.15
  • NVAX $6.67
  • Analyst Decision
  • DESP Hold
  • NVAX Buy
  • Analyst Count
  • DESP 5
  • NVAX 6
  • Target Price
  • DESP $17.20
  • NVAX $17.83
  • AVG Volume (30 Days)
  • DESP 2.8M
  • NVAX 7.5M
  • Earning Date
  • DESP 05-15-2025
  • NVAX 05-09-2025
  • Dividend Yield
  • DESP N/A
  • NVAX N/A
  • EPS Growth
  • DESP N/A
  • NVAX N/A
  • EPS
  • DESP N/A
  • NVAX N/A
  • Revenue
  • DESP $756,296,000.00
  • NVAX $682,162,000.00
  • Revenue This Year
  • DESP $10.71
  • NVAX $1.07
  • Revenue Next Year
  • DESP $8.90
  • NVAX N/A
  • P/E Ratio
  • DESP N/A
  • NVAX N/A
  • Revenue Growth
  • DESP 16.73
  • NVAX N/A
  • 52 Week Low
  • DESP $9.25
  • NVAX $3.92
  • 52 Week High
  • DESP $19.55
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • DESP 53.05
  • NVAX 49.32
  • Support Level
  • DESP $19.09
  • NVAX $5.81
  • Resistance Level
  • DESP $19.29
  • NVAX $7.81
  • Average True Range (ATR)
  • DESP 0.18
  • NVAX 0.67
  • MACD
  • DESP 0.02
  • NVAX 0.15
  • Stochastic Oscillator
  • DESP 76.10
  • NVAX 59.29

About DESP Despegar.com Corp.

Despegar.com Corp is an online travel company in Latin America. Its product offering includes airline tickets, packages, hotels, and other travel-related products, which enables consumers to find, compare, plan and purchase travel products easily through its marketplace. The company provides a technology platform for managing the distribution of products and access to users to the network of travel suppliers. It operates through two segments: Air, which consists of the sale of airline tickets; and Packages, Hotels, and Other Travel Products, which consists of travel packages, as well as sales of hotel rooms, car rentals, bus tickets, cruise tickets, travel insurance and destination services. Its geographical segments are Argentina, Brazil, Uruguay, Mexico, and other countries.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: